The global oral antiseptics market is slated to be valued at USD 2.47 Billion in 2022. Sales of oral antiseptics are predicted to increase at a CAGR of 4.7% from 2022 to 2028 and reach a valuation of USD 3.24 Billion by 2028.
| Attribute | Details |
|---|---|
| Oral Antiseptics Market Size (2022) | USD 2.47 Billion |
| Estimated Market Value (2028) | USD 3.24 Billion |
| Global Market Growth Rate (2022 to 2028) | 4.7% CAGR |
| Dominant Distribution Channel | Hypermarkets/Supermarkets - 43.6% |
Increasing focus on oral care has majorly fostered demand for oral antibiotics and oral medication across the world. Rising popularity of organic medication is expected to boost demand for natural oral antiseptics. Worldwide shipments of oral antiseptics account for 5.2% share of the global oral care market.
| Particulars | Details |
|---|---|
| H1, 2021 | 4.65% |
| H1, 2022 Projected | 4.66% |
| H1, 2022 Outlook | 4.36% |
| BPS Change - H1, 2022 (O) – H1, 2022 (P) | (-) 30 ↓ |
| BPS Change – H1, 2022 (O) – H1, 2021 | (-) 29 ↓ |
The variation between the BPS values observed within this market in H1, 2022 - outlook over H1, 2022 projected reflects a decline of 30 BPS units. However A positive BPS growth in H1-2022 over H1-2021 by 29 Basis Point Share (BPS) is demonstrated by the oral antiseptics market.
The market observed a decline in the BPS values owed to the reduced patient in-flow for standards medical procedures, such as dentistry, which employs the use of oral antiseptics on a routine basis. The decreased procedural adoption rate was owed to the shut-down of several private and independent clinics in lieu of the advent of the COVID-19 pandemic.
However, with the development of oral antiseptic formulations with properties to target antimicrobial resistant bacteria will be likely to present a positive outlook towards growth of the market over the forecast period.
The key developments in the market include the introduction of oral antiseptics with rapid antiviral action for the management of the SARS-CoV-2 infection. The market is subject to aspects concerning drug regulations and licensing, as per the macroeconomic and industry dynamics.
Increasing instances of oral infections and oral diseases are majorly driving demand for oral medications, oral vaccines, oral antibiotics, etc. From 2013 to 2021, demand for oral antiseptics rose at a CAGR of 4.3%.
Topical antiseptics for mouth infections such as canker sores, ulcers, etc., are anticipated to see an increase in demand as focus on oral hygiene bolsters. Chlorhexidine dental solutions and other antiseptic oral cleansers are expected to see an increasing demand from dental professionals.
Increasing awareness for oral hygiene, changing consumer preferences, increasing awareness of preventive healthcare, rising healthcare spending and expenditure, increasing instances of oral diseases, poor dental hygiene of population, etc., are major factors that influence oral antiseptic sales.
Antiseptics for mouth ulcers, antiseptics for canker sores, etc., are anticipated to see increase in demand as lifestyle habits deteriorate and cause oral infections. Consumption of oral antiseptics is anticipated to rise at a CAGR of 4.7% from 2022 to 2028.
Rising Consumer Preference for Natural Oral Antiseptics
Consumers and patients across the world are leaning towards organic and natural medication as they refrain from intake of chemicals. Natural antiseptics for the mouth are being developed by multiple oral antiseptics manufacturers. Observed discomfort from chlorhexidine oral solutions and hexetidine oral solutions are expected to further bolster demand for natural oral antiseptics.
Consumption of Oral Antiseptics to See Hike across Emerging Economies
Market scrutiny for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been discussed in detail in this oral antiseptics research report by FMI.
Mouth antiseptics are anticipated to see high demand from dental practitioners in the North American region. Increasing focus on dental hygiene and the prevalence of oral diseases are expected to be major trends influencing oral antiseptic consumption in this region.
Oral antiseptic solutions are estimated to see high demand in Europe as a focus on oral care bolsters. Increasing awareness about the side effect of chemicals is expected to propel the demand for natural oral antiseptic solutions.
Increasing focus on healthcare, rising oral infections, increasing geriatric population, and rising per capita disposable income are some factors that influence sales of oral antiseptics in regions such as East Asia, South Asia, and MEA. Oral antiseptic consumption is predicted to be high in emerging economies such as India and China.
Demand for oral antiseptics is anticipated to rise at a moderate pace across Latin America and MEA due to lack of awareness about oral care and less healthcare spending potential. By the end of the forecast period, as healthcare expenditure increases, oral antiseptic manufacturers can focus on these regions and benefit from the untapped market potential.
Increasing Use of Topical Antiseptic Solutions by Dental Professionals
The USA is known for its well-established healthcare infrastructure and is a highly lucrative market for sales of all kinds of healthcare products. Topical oral antiseptic solutions are expected to see a rise in demand as instances of mouth infections increase substantially. Chlorhexidine dental solutions and antiseptic oral cleansers are expected to see high demand from dental professionals in the USA.
Increasing Healthcare Awareness to Drive Demand for Topical Antiseptics for Mouth Infections
The Indian healthcare infrastructure has seen substantial developments in the past few years and this has fostered demand for oral antiseptic solutions. Increasing disposable income, rising focus on oral care, increasing consumer preference for natural antiseptic solutions, and the declining popularity of chlorhexidine oral solutions due to their side effects are anticipated to influence market potential in India.
Antiseptics for mouth ulcers, antiseptics for mouth infections, and antiseptics for canker sores are projected to see high demand as awareness regarding oral care increases across India.
Sales via Supermarkets & Hypermarkets Expected to Have a Dominant Outlook
Oral antiseptic solutions do not require medical prescriptions and are easily accessible to the general population via multiple distribution channels. The majority of sales are through supermarkets and hypermarkets which cumulatively account for 43.6% of the global oral antiseptic demand.
Drug stores account for 30.2% of the global sales of oral antiseptics in 2022. Distribution via retail pharmacies and e-commerce channels holds a market share of 19.5% and 6.7% respectively at present.
Oral antiseptic suppliers are investing in the research & development of natural oral antiseptics as their preference rises among the general population. Oral antiseptic companies are also adopting multiple organic and inorganic marketing strategies to boost their sales across multiple regions.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2028 |
| Historical Data Available for | 2013 to 2021 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
| Key Market Segments Covered | Product Type, Distribution Channel, Region |
| Key Companies Profiled | Procter & Gamble; Revive Personal Products Company; 3M; Colgate-Palmolive; Johnson & Johnson; Dentaid SL; ICPA Health Products; Cipla Inc.; Church & Dwight Inc.; Dentsply Sirona |
| Pricing | Available upon Request |
Table 01: Expenditure on Health, (% of GDP), by Country, 2013–2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2013–2021
Table 03: Global Oral Antiseptics Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028, By Product Type
Table 04: Global Oral Antiseptics Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028 By Distribution Channel
Table 05: Global Oral Antiseptics Market size (US$ Mn) Analysis 2013–2021 and Forecast 2022–2028 By Region
Table 06: North America Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 07: North America Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 08: North America Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 09: Latin America Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 10: Latin America Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 11: Latin America Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 12: Europe Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 13: Europe Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 14: Europe Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 15: South Asia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 16: South Asia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 17: South Asia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 18: East Asia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 19: East Asia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 20: East Asia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 21: Oceania Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 22: Oceania Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 23: Oceania Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 24: MEA Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Country
Table 25: MEA Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 26: MEA Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 27: India Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 28: India Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 29: Australia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 30: Australia Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Table 31: Brazil Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Product Type
Table 32: Brazil Oral Antiseptics Market Analysis 2013-2021 and Forecast 2022-2028, By Distribution Channel
Figure01: GlobalOralAntisepticsMarketValueAnalysisandForecast,2021–2028(US$Mn)
Figure02: GlobalOralAntisepticsMarketAbsolute$Opportunity(US$Mn),2013–2021
Figure03: GlobalOralAntisepticsMarketAbsolute$Opportunity(US$Mn),2021–2028
Figure04: OralAntisepticsMarketIncrementalOpportunityUS$,byProductType
Figure05: OralAntisepticsMarketAbsoluteOpportunityUS$,byProductType
Figure06: OralAntisepticsMarketShare%,byProductType,2022E
Figure07: OralAntisepticsMarketShare%,byProductType,2028F
Figure08: GlobalOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure09: OralAntisepticsMarketIncrementalOpportunityUS$,byDistributionChannel
Figure10: OralAntisepticsMarketShare%,byDistributionChannel,2022E
Figure11: OralAntisepticsMarketAbsoluteOpportunityUS$,byDistributionChannel
Figure12: OralAntisepticsMarketShare%,byDistributionChannel,2028F
Figure13: GlobalOralAntisepticsMarketAttractivenessAnalysis,ByDistributionChannel
Figure14: OralAntisepticsMarketIncrementalOpportunityUS$,byRegion
Figure15: OralAntisepticsMarketAbsoluteOpportunityUS$,byRegion
Figure16: OralAntisepticsMarketShare%,byRegion,2022E
Figure17: OralAntisepticsMarketShare%,byRegion,2028F
Figure18: GlobalOralAntisepticsMarketAttractivenessAnalysis,ByRegion
Figure19: NorthAmericaOralAntisepticsMarketValueShare,ByProductType
Figure20: NorthAmericaOralAntisepticsMarketValueShare,ByDistributionChannel
Figure21: NorthAmericaOralAntisepticsMarketValueShare,ByCountry
Figure22: NorthAmericaOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure23: NorthAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure24: USOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure25: USOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure26: CanadaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure27: CanadaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure28: NorthAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byCetylpyridiniumChlorideBased
Figure29: NorthAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byCetylpyridiniumChlorideBased
Figure30: NorthAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byChlorhexidineGluconateBased
Figure31: NorthAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byChlorhexidineGluconateBased
Figure32: NorthAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byHerbalProduct
Figure33: NorthAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byHerbalProduct
Figure34: NorthAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byEssentialOils
Figure35: NorthAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byEssentialOils
Figure36: NorthAmericaOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure37: NorthAmericaOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure38: NorthAmericaOralAntisepticsMarketAttractivenessAnalysis,ByCountry
Figure39: LatinAmericaOralAntisepticsMarketValueShare,ByProductType
Figure40: LatinAmericaOralAntisepticsMarketValueShare,ByDistributionChannel
Figure41: LatinAmericaOralAntisepticsMarketValueShare,ByCountry
Figure42: LatinAmericaOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure43: LatinAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure44: BrazilOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure45: BrazilOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure46: MexicoOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure47: MexicoOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure48: RestofLatinAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure49: RestofLatinAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure50: LatinAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byCetylpyridiniumChlorideBased
Figure51: LatinAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byCetylpyridiniumChlorideBased
Figure52: LatinAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byChlorhexidineGluconateBased
Figure53: LatinAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byChlorhexidineGluconateBased
Figure54: LatinAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byHerbalProduct
Figure55: LatinAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byHerbalProduct
Figure56: LatinAmericaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byEssentialOils
Figure57: LatinAmericaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byEssentialOils
Figure58: LatinAmericaOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure59: LatinAmericaOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure60: LatinAmericaOralAntisepticsMarketAttractivenessAnalysis,ByCountry
Figure61: EuropeOralAntisepticsMarketValueShare,ByProductType
Figure62: EuropeOralAntisepticsMarketValueShare,ByDistributionChannel
Figure63: EuropeOralAntisepticsMarketValueShare,ByCountry
Figure64: EuropeOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure65: EuropeOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure66: U.K.OralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure67: U.K.OralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure68: GermanyOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure69: GermanyOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure70: FranceOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure71: FranceOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure72: ItalyOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure73: ItalyOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure74: SpainOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure75: SpainOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure76: BENELUXOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure77: BENELUXOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure78: RussiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure79: RussiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure80: RestofEuropeOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure81: RestofEuropeOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure82: EuropeOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byCetylpyridiniumChlorideBased
Figure83: EuropeOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byCetylpyridiniumChlorideBased
Figure84: EuropeOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byChlorhexidineGluconateBased
Figure85: EuropeOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byChlorhexidineGluconateBased
Figure86: EuropeOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byHerbalProduct
Figure87: EuropeOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byHerbalProduct
Figure88: EuropeOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byEssentialOils
Figure89: EuropeOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byEssentialOils
Figure90: EuropeOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure91: EuropeOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure92: EuropeOralAntisepticsMarketAttractivenessAnalysis,ByCountry
Figure93: SouthAsiaOralAntisepticsMarketValueShare,ByProductType
Figure94: SouthAsiaOralAntisepticsMarketValueShare,ByDistributionChannel
Figure95: SouthAsiaOralAntisepticsMarketValueShare,ByCountry
Figure96: SouthAsiaOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure97: SouthAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure98: IndiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure99: IndiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure100: ThailandOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure101: ThailandOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure102: IndonesiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure103: IndonesiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure104: MalaysiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure105: MalaysiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure106: RestofSouthAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure107: RestofSouthAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure108: SouthAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byCetylpyridiniumChlorideBased
Figure109: SouthAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byCetylpyridiniumChlorideBased
Figure110: SouthAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byChlorhexidineGluconateBased
Figure111: SouthAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byChlorhexidineGluconateBased
Figure112: SouthAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byHerbalProduct
Figure113: SouthAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byHerbalProduct
Figure114: SouthAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byEssentialOils
Figure115: SouthAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byEssentialOils
Figure116: SouthAsiaOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure117: SouthAsiaOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure118: SouthAsiaOralAntisepticsMarketAttractivenessAnalysis,ByCountry
Figure119: EastAsiaOralAntisepticsMarketValueShare,ByProductType
Figure120: EastAsiaOralAntisepticsMarketValueShare,ByDistributionChannel
Figure121: EastAsiaOralAntisepticsMarketValueShare,ByCountry
Figure122: EastAsiaOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure123: EastAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure124: ChinaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure125: ChinaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure126: JapanOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure127: JapanOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure128: SouthKoreaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure129: SouthKoreaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure130: EastAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byCetylpyridiniumChlorideBased
Figure131: EastAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byCetylpyridiniumChlorideBased
Figure132: EastAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byChlorhexidineGluconateBased
Figure133: EastAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byChlorhexidineGluconateBased
Figure134: EastAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byHerbalProduct
Figure135: EastAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byHerbalProduct
Figure136: EastAsiaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byEssentialOils
Figure137: EastAsiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byEssentialOils
Figure138: EastAsiaOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure139: EastAsiaOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure140: EastAsiaOralAntisepticsMarketAttractivenessAnalysis,ByCountry
Figure141: OceaniaOralAntisepticsMarketValueShare,ByProductType
Figure142: OceaniaOralAntisepticsMarketValueShare,ByDistributionChannel
Figure143: OceaniaOralAntisepticsMarketValueShare,ByCountry
Figure144: OceaniaOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure145: OceaniaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure146: AustraliaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure147: AustraliaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure148: NewZealandOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure149: NewZealandOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure150: OceaniaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byCetylpyridiniumChlorideBased
Figure151: OceaniaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byCetylpyridiniumChlorideBased
Figure152: OceaniaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byChlorhexidineGluconateBased
Figure153: OceaniaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byChlorhexidineGluconateBased
Figure154: OceaniaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byHerbalProduct
Figure155: OceaniaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byHerbalProduct
Figure156: OceaniaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byEssentialOils
Figure157: OceaniaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byEssentialOils
Figure158: OceaniaOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure159: OceaniaOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure160: OceaniaOralAntisepticsMarketAttractivenessAnalysis,ByCountry
Figure161: MEAOralAntisepticsMarketValueShare,ByProductType
Figure162: MEAOralAntisepticsMarketValueShare,ByDistributionChannel
Figure163: MEAOralAntisepticsMarketValueShare,ByCountry
Figure164: MEAOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure165: MEAOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure166: SouthAfricaOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure167: SouthAfricaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure168: GCCCountriesOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure169: GCCCountriesOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure170: RestofMEAOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021
Figure171: RestofMEAOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure172: MEAOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byCetylpyridiniumChlorideBased
Figure173: MEAOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byCetylpyridiniumChlorideBased
Figure174: MEAOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byChlorhexidineGluconateBased
Figure175: MEAOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byChlorhexidineGluconateBased
Figure176: MEAOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byHerbalProduct
Figure177: MEAOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byHerbalProduct
Figure178: MEAOralAntisepticsMarketSize(US$Mn)Analysis,2013–2021,byEssentialOils
Figure179: MEAOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028,byEssentialOils
Figure180: MEAOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure181: MEAOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure182: MEAOralAntisepticsMarketAttractivenessAnalysis,ByCountry
Figure183: OralAntisepticsMarketValueProportionAnalysis,ByKeyCountries
Figure184: GlobalVs.Country,Y-O-YGrowthComparison
Figure185: IndiaOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure186: IndiaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure187: IndiaOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure188: IndiaOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure189: AustraliaOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure190: AustraliaOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure191: AustraliaOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure192: AustraliaOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
Figure193: BrazilOralAntisepticsMarketsize(US$Mn)Analysis,2013–2021
Figure194: BrazilOralAntisepticsMarketValue(US$Mn)&Y-o-YGrowth(%),2022–2028
Figure195: BrazilOralAntisepticsMarketAttractivenessAnalysis,ByProductType
Figure196: BrazilOralAntisepticsMarketAttractivenessAnalysis,ByDistributionchannel
In 2022, the global oral antiseptics market stands at a valuation of USD 2.47 Billion.
From 2022 to 2028, demand for oral antiseptics is expected to increase at a CAGR of 4.7%.
By 2028, the global oral antiseptics market size is anticipated to reach an estimated value of USD 3.24 Billion.
Oral antiseptic sales via supermarkets and hypermarkets account for a dominant market share of 43.6%.
Prominent oral antiseptic manufacturers such as Procter & Gamble, Revive Personal Products Company, 3M, Colgate-Palmolive, Johnson & Johnson, Dentaid SL, ICPA Health Products, and Cipla Inc. have been detailed in this analysis.
Explore Similar Insights
Oral Antiseptics Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
